Extrahepatic Portal Vein Obstruction in the Pediatric Age: A Medical Challenge
Journal Title: Journal of Clinical Gastroenterology and Treatment - Year 2016, Vol 2, Issue 4
Abstract
Extrahepatic portal vein obstruction (EHPVO), although rare in children, is a significant cause of portal hypertension (PHT) which leads to life-threatening gastrointestinal bleeding in the pediatric age group. PHT may also lead to other complications such as hypersplenism, cholangiopathy, ascites, and even hepatopulmonary syndrome and portopulmonary hypertension that may require organ transplantation.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP343732
- DOI 10.23937/2469-584X/1510035
- Views 124
- Downloads 0
Portal Hypertension Does Not Preclude the Efficacy of Direct-acting Anti-Hepatitis C Viral Therapy
Purpose: This study aimed to investigate whether patients with hepatitis C virus (HCV)-related cirrhosis and clinically significant portal hypertension (CSPH) could show satisfactory virological and safety outcomes on di...
Trends in Inflammatory Bowel Disease- Comparison Between the Arab and Jewish Population in Israel
Introduction: Genetic and environmental factors have a major influence on the pathophysiology of inflammatory bowel disease (IBD). Older studies reported a very low prevalence of IBD among the Arab population in Israel....
Extrahepatic Portal Vein Obstruction in the Pediatric Age: A Medical Challenge
Extrahepatic portal vein obstruction (EHPVO), although rare in children, is a significant cause of portal hypertension (PHT) which leads to life-threatening gastrointestinal bleeding in the pediatric age group. PHT may a...
Diarrhea as First Symptom in Systemic Erythematous Lupus in Child - A Case Report
The systemic erythematous lupus (LES) is a chronic inflammatory disease of autoimmune aetiology, characterized by the involvement of multiple organs and systems. It can be related to the production of different antibodie...
Hepatotoxicity from Alpha-Methyldopa During Pregnancy: Two Case Reports
Abstract: A 29-year-old woman in her third pregnancy (at 22 weeks), with a history of arterial hypertension under treatment with enalapril, which medication was switched to α-methyldopa on gestation week 8. She then bega...